Educational Chart Set ups

//Educational Chart Set ups

Portola Pharmaceuticals Inc (PTLA)- FDA approved. 6.23.17

FDA approved BEVYXXA https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208383 Full prescribing information https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf

By | June 23rd, 2017|Educational Chart Set ups, Public Access|0 Comments

CARA, CLVS, GEMP, Three biotech with upcoming trial data. Ideas. 5.31.17

Stock and macro calendar http://www.precisiontrade365.com/stock-and-macro-calendar/ Tomorrow starts of a new month and these are some biotech ideas to watch in June. #CARA- Top-line data expected in 2Q, phase 2b trial Oral CR845 http://ir.caratherapeutics.com/releasedetail.cfm?ReleaseID=1024907 #CLVS- ARIEL3 results end of June http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle_Print&ID=2269437 #GEMP-  Top-line COLBALT1-Phase 2b trial expected late June http://ir.gemphire.com/phoenix.zhtml?c=254241&p=irol-newsArticle&ID=2271147 Thanks for reading. ~PT365

By | May 31st, 2017|Educational Chart Set ups, Public Access|0 Comments

PANW a look back at our options highlights. Chart $STUDY. 5.31.17

#PANW Palo Alto Networks Inc, Q3 adjusted EPS 61c vs 55c consensus, revenue $431.80m vs $411.92m on April 25, 2017 when stock was at $100.40, our team highlighted the June 16, 120c with 6,767 volumes ask price at $2.90. With today closed, the June 16, 120c ask at $5.20 for nearly double, but [...]

By | May 31st, 2017|Educational Chart Set ups, Public Access|0 Comments

AERI, PBYI, RDUS Three biotech news recap. 5.24.17

#AERI Aerie Pharmaceuticals Reports Positive Roclatan™ (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% Phase 3 Topline Efficacy Results https://finance.yahoo.com/news/aerie-pharmaceuticals-reports-positive-roclatan-200100906.html #PBYI Puma Biotechnology Receives FDA Advisory Committee Support for Neratinib http://investor.pumabiotechnology.com/press-release/puma-biotechnology-receives-fda-advisory-committee-support-neratinib #RDUS Radius Announces Positive Top-Line Results from Completed ACTIVExtend Study for TYMLOS™ in Postmenopausal Women with Osteoporosis https://finance.yahoo.com/news/radius-announces-positive-top-line-200000822.html

By | May 24th, 2017|Educational Chart Set ups, Public Access|0 Comments

#PBYI briefing document highlights & chart notes. Public idea. 5.22.17

Stock and Macro calendar http://www.precisiontrade365.com/stock-and-macro-calendar/ #PBYI released FDA 152 pages of briefing document here https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM559728.pdf More content from FDA.gov website https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm559714.htm Always do your own due diligence to be informed. These are idea and opinion only. some highlights from briefing documents: Before and after charts share to members Before, as of May 19, 2017 closed. after, [...]

By | May 22nd, 2017|Educational Chart Set ups, Public Access|0 Comments

CLVS, PBYI these two biotech with upcoming catalyst. Public ideas. 5.17.17

These are ideas only. Always do your own due diligence. Details notes and guides are for members. #CLVS- catalyst top-line ARIEL3 data anticipated end of June http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle&ID=2269437 2. #PBYI- catalyst Oncology Drugs Advisory Committee, May 24. Stocks and Macro calendar http://www.precisiontrade365.com/stock-and-macro-calendar/

By | May 17th, 2017|Educational Chart Set ups, Public Access|0 Comments

AKBA our elite stock pick has hit 30% target. See our notes. 4.25.17

Elite small cap biotech pick hit target. Trim and trail. Blog article on 3/07/17 http://www.precisiontrade365.com/new-small-cap-biotech-idea-3-7-17/  Chart on March 7, 2017 pick for elite membership.  after chart as of April 4/25/17

CAPR, SRPT two biotech ideas for tomorrow. 4.24.17

CAPR  Capricor Therapeutics to Report Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy. http://finance.yahoo.com/news/capricor-therapeutics-report-six-month-203000017.html Conference Tuesday, April 25 at 8am ET. Share +19.74% after hours SRPT +0.47% after hours. Watch for reaction trade tomorrow Charts:

By | April 24th, 2017|Educational Chart Set ups, Public Access|0 Comments

Fresenius Kabi to acquired Akorn $34 per share. Right at our projection target. Congrats long. $AKRX $IBB

Fresenius Kabi to acquired Akorn, a $4.30 billion or $34 per share. Press release  http://finance.yahoo.com/news/fresenius-kabi-acquire-akorn-205800399.html Stock closed on April 24, 2017 at $32.72 Here is our chat and notes to member on Friday 7, 2017.

By | April 24th, 2017|Educational Chart Set ups, Public Access|0 Comments

Free 5 days trial!

Good evening newsletters subscribers, We hope you like our public newsletters information in the past months, we would like to invite you to join our FREE TRIAL chat room and site access for the week, April 17-21,2017. If you are interested, email to us support@precisiontrade365.com with subject "Free trial". NO CREDIT CARD needed. Our team [...]

By | April 13th, 2017|Educational Chart Set ups, Public Access|0 Comments

Please contact us!

Please leave us your phone and we call you back!

We never share this data with 3rd part companies.

Thank you!
We got your message
We will answer in the next 24h